Clinical Trial Update: House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma [Phase 3]

View source ↗

Summary

The MITRA trial, a Phase 3 study evaluating house dust mite immunotherapy for asthma, has completed. The sponsor is ALK-Abelló A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ACARIZAX (house dust mite sublingual immunotherapy tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Asthma | Phase 3 | Status: COMPLETED